Skip to main content

Table 3 Adverse events

From: Blind bedside postpyloric placement of spiral tube as rescue therapy in critically ill patients: a prospective, tricentric, observational study

Events, number (percentage) Value in total study sample (n = 127)
Any event 33 (26.0)
MATEs 29 (22.8)
 Vital signs alert eventsa 15 (11.8)
 Requirement of sedatives or analgesics during procedure 14 (11.2)
 Nausea 8 (6.3)
 Pain 6 (4.7)
 Nasal mucosa bleeding 5 (3.9)
 Vomiting 3 (2.4)
Metoclopramide-associated events 5 (4.0)
 Amyostasia 2 (1.6)
 Lethargy 1 (0.8)
 Dysphoria 1 (0.8)
 Xerostomia 1 (0.8)
  1. Qualitative variables are presented as number (percentage)
  2. MATEs major adverse tube-associated events
  3. aDefined as any vital sign that fluctuated beyond the range of ± 15%, or pulse oxygen saturation that declined to < 90%